chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12/3/2009 Pat. is exhausted, sob, palpitations, has a viral infection since last Tuesday. Also back spasms. Did not check blood sugars. Her joints hurt due to inability of getting shots, as she has this viral infection. Is not on prednisone. 12/6/2009 "Extreme weakness in my hips and shoulders." It is bilateral. It has been going on for a number of days. She has had no fever or chills. She has also had no specific injury, although, she did fall and injure her right ankle, which seems relatively minor on further questioning and quick exam. Her chief complaint is as above. Further questioning that she has had some significant dyspnea on exertion. The patient states that she seemed to get the flu several weeks ago and had a headache, which was gradual in onset and no stiff neck or fever then that was right before Thanksgiving. By the day following Thanksgiving, she started to note dyspnea on exertion. It was not sudden and it did not occur at rest. There is no chest pain, pressure, and heavy. Because of this, she was seen in this Emergency Department and she was on a Z-PAK for probable sinus problems from her headache. She was subsequently seen two days ago and placed on doxycycline despite what the chart says. The patient also has some migratory back pain more in the low back now. There is no specific weakness, numbness, tingling, or any bowel or bladder symptoms. She does, however, have some tingling in both arms and legs primarily distally in the feet and hands. There is no weakness and there is no true numbness. There is no asymmetry. Although, the patient was treated with antibiotics, she has not had any real cough, or sputum production, or bronchitis or pneumonia symptoms. There is also no other head cold, unusual sinus, or progressive ENT symptoms. No bladder or bowel.
Received only the MMR vaccine. Swelling and hives near injection site. Occurred within less than 5 minutes of administration of the MRR injection.
Unremitting pain, burning sensation in stomach started at  6, pm  followed by chills and fever, and vomiting from 9 to 10 pm
I experienced a hives rash from my left breast, upper chest, around the neck, and across the sternum to the right side of my breast. I called my doctor the next day and he had me to come before my radiation treatment and asked me to take Benadryl (also took it the night before when it first started to appear).  It took 4 to 5 days before the rash went away after taking Benadryl.
Shots given at about 2 PM, at 3:30 child c/o headache, stomach "hurt" and skin was hot to touch. Temp not taken, TYLENOL given. Also c/o "eyes burning." The next AM, he had a generalized "goose bumps" type rash, that itched. There was a quarter sized induration on her (R) arm - site of MCV4 vaccine. Rash on leg relieved somewhat by BENADRYL, but rash lasted 2 days.
After vaccination patient passed out approximately 15-30 seconds. Ammonia Inhalant administered immediately. Patient was observed in office for 30 minutes prior to leaving.
Received dose 12/22/2020 at approximately 14:15. No adverse effects at that time, mild soreness at injection site.. On 12/30/2020, at approximately 1900 I noted that the area where I had been injected had become erythemic and indurated approximately 3cm in diameter, area was also hot to the touch
Baseball sized lump (deltoid) 2 mm scattered papules heavily on trunk, arms and leg few on face.
Patient reported arm was red, itchy, swollen, and warm 6 inches below site of vaccine injection. Patients arm is still red and swollen but has improved over the past week.
Severe Headache for five-six days. Took over the counter headache, migraine, tension headache, and Aleve to attempt to alleviate symptoms.  On the sixth day (Thursday) headache finally subsided enough to not have to take pain medication to control it.
Received half dose of flu vaccine Nov. 11, 2006.  That day developed fever, confusion. Has had a progressive decline in cognitive function to point she is totally aphasic, bed bound, dysphagia.  Now hospitalized with what appears to be Jacob-Cruetfeldt disease whose symptoms began the day of the flu vaccine.  1/18/07 Received medical records from hospital which reveal patient admitted 12/28/06-1/5/07 with rapid onset & marked mental deteriorationfever, confusion,  global aphasia & ataxia with occasional myoclonic jerks over an approx 6 wk course beginning same day as receied 1/2 dose flu vax due to her egg allergy. Patient had been mentally intact & running her own business prior to receiving flu vax. Developed URI symptoms a few days prior to admit.  While hospitalized, continued steady decline with increased myoclonic activity & developed left facial droop. IV infiltrate site developed cellulitis & left eye developed conjunctivitis, both treated with antibiotics. FINAL DX: Jakob-Creutzfeldt disease.  Patient placed in hospice. Per 60 day follow up: Patient expired. Diagnosis JACKOB-CREUTZFELDT disease
At approximately 4:30 pm on June 24, 2019, when I stood up, head to toe every single muscle and joint was stiff. I was trying to finish some work on my computer and everything came on all of a sudden. I had an uneasy pain feeling in my head and I struggled through the pain just to get my work finished. I took some Advil for my headache and went to bed right after taking the Advil. As soon as I laid in bed, I started shaking uncontrollably because I felt so cold and my teeth were chattering. I was unable to stop either of these things. And then came the fever which started at 101 degrees F and peaked overnight at 103 degrees F. The next day, June 25, 2019, I woke up and my head was off--it felt very cloudy, I had a super bad headache and the fever continued to go up and down throughout the day. My wife and I went to the walk-in, at the clinic (in the same building as my primary care doctor), and I was seen around 8:30 am. They did bloodwork and mentioned testing my white blood count and checking for Lyme disease. They also did an EKG which came back normal. The doctor called me later to tell me my white blood cell count was fine, and liver and kidney function was also fine. I still have not heard anything back in regards to the Lyme disease testing. The walk-in doctor thought I may have a sinus infection and I was prescribed an antibiotic for that. I didn't think it was a sinus infection, because normally when I get those I have dark nasal discharge and this time I didn't have any. After leaving the walk-in, I went home to rest and I started the antibiotic the walk-in had prescribed. Later that night, I  went to use the bathroom, and my pee was very dark yellow and had a brown plume disperse in it. I also started feeling very itchy all over. I went to bed and battled with a fever again that night. It went to a high of 102 degrees F that night. The next day, June 26, 2019, I stopped the antibiotic because I was still itchy and thought I might be having a reaction to the antibiotic. I took a total of 3 doses of the antibiotic before stopping it. My fever had stopped by this day but I was very sweaty all over my body. The sweatiness lasted all day. My head was still off and felt cloudy. The next day, June 27, 2019, I was feeling much better, but not 100%. I still had a cloudy head but it seemed to be improving. I felt like I was getting my strength back. The following day, June 28, 2019, I was basically back to normal, with only a slight headache. Throughout this whole process, I tried to contact my primary care provider. My wife originally spoke with the on-call doctor, who said they would forward a message to my PCP. To date, we still have not heard anything back from her.
Information has been received from a nurse concerning an unknown number of unspecified patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not provided. On unknown dates in 2016 (reported as "since August 2016"), the patients were vaccinated with doses improperly stored RECOMBIVAX HB (lot #, expiration date, dose and route were unknown). No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
I had a fever that was worse (103) than the last time and headache that lasted a day.
TOOK UNREFRIGERATED VIVOTIF; This spontaneous case report (PVX2019-2838) was received from a pharmacist on 16-Nov-2019. It described a consumer who "took unrefrigerated Vivotif" (PT: Product storage error). She was receiving Vivotif for an unknown indication.  Case report: The consumer took Vivotif that was kept out of the refrigerator for weeks.  Action taken with Vivotif with respect to the reported event was not applicable.  The clinical outcome of the reported event was unknown.  Company Comment: It was reported that a patient took unrefrigerated Vivotif which was kept out of the refrigerator for weeks (Product storage error). The causality of the event is assessed as not related to Vivotif. .; Sender's Comments: It was reported that a patient took unrefrigerated Vivotif which was kept out of the refrigerator for weeks (Product storage error). The causality of the event is assessed as not related to Vivotif.
Patient was readmitted for fever (101-103), myalgias/arthralgias, muscle weakness until fever resolution.  Hospital course may have been lengthened by other conditions, not directly related to potential vaccine reaction.
Shots administered about 11:30 6/9/06 right thigh swollen, noticed 6/10/06 about 8pm from knee up about 1-2".
Cough, chest congestion, sinus, fever. Children at home had been ill same week she received vaccine.
Right after vaccination syncope occurred with loss of vision, pale complexion, sweating, light headed ness, etc. for about 10 minutes after
A patient received a Moderna vaccine this am from a vial that was punctured at 3pm on 22Sep2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient received a Moderna vaccine this am from a vial that was punctured at 3pm on 22Sep2021) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Sep-2021 at 9:52 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In September 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient received a Moderna vaccine this am from a vial that was punctured at 3pm on 22Sep2021). In September 2021, EXPIRED PRODUCT ADMINISTERED (A patient received a Moderna vaccine this am from a vial that was punctured at 3pm on 22Sep2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Significant followup received & updated patient demographics and updated suspect details
Hypersensitivity to vaccine (not sure); Severe rash on his both arms; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity to vaccine (not sure)) and RASH (Severe rash on his both arms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity to vaccine (not sure)) and RASH (Severe rash on his both arms). At the time of the report, HYPERSENSITIVITY (Hypersensitivity to vaccine (not sure)) and RASH (Severe rash on his both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.  Treatment information was not provided.  .   Reporter did not allow further contact
first booster on 2/14/2020 / gave him another booster on 8/03/2021; This case was reported by a consumer via call center representative and described the occurrence of extra dose administered in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Previously administered products included Menveo (patient received the vaccine on 16th October 2014) and Menveo (1st booster dose received on 14th February 2020).   On 3rd August 2021, the patient received Menveo. On 3rd August 2021, unknown after receiving Menveo, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: The case was reported by patient mother. The patient received an extra booster of Menveo, which led to extra dose administered. The reporter asked if patient mother had the lot numbers for the 3 doses and she did not however she stated that per the documentation she has they all are listed as MCV40 Menveo. The reporter did not consented to follow up.
Vaccinations given at 1:30 3/13/19, approx 0730 AM 03/14/19 friends at school noted her face was flushed, no swelling or itching. Patient noticed arms felt warm. Given 25 mg BENADRYL 200 mg MOTRIN and mother brought to office at 10 AM 03/14/19 - Arms were fine, rash on face largely gone slight itch. Rash resolved after 2 days per mother.
small rash on neck and face; This spontaneous case was reported by a consumer and describes the occurrence of RASH (small rash on neck and face) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Seasonal allergy and Shellfish allergy. Concomitant products included TAMOXIFEN and BETAHISTINE HYDROCHLORIDE (VERTEX [BETAHISTINE HYDROCHLORIDE]) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced RASH (small rash on neck and face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ALLERGY & SINUS) at an unspecified dose and frequency. At the time of the report, RASH (small rash on neck and face) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-026437, MOD-2021-026437 (Patient Link).
soreness arm; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a adolescent female patient who received Men B NVS (Bexsero) for prophylaxis.   On 3rd June 2019, the patient received Bexsero. In June 2019, less than a month after receiving Bexsero, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of Bexsero 1 week ago and experiencing a sore arm. The soreness had not resolved. The reporter did not had any additional details.
headache immediately after immunizations of Tdap & menningococcal. later that day had fever 102.1F, dizziness, nausea, aching, worsening headache 10/10 pain scale with vomiting last night. pain today 6/10 (headache)
This case was reported by a pharmacist and described a 34 year old male subject who tested positive for hepatitis B surface antigen following vaccination with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. Medical history included renal failure (cause not specified) requiring hemodialysis, hypertension, anemia and diabetes. Concurrent medications included Epoetin alfa, Venofer, Paricalcitol, Spironolactone, Nephro-Vite, Lisinopril, Warfarin sodium, Sevelamer hydrochloride, and sodium bicarbonate. The indications for the concurrent medications were not provided. On 8/17/2005 the subject received the 4 dose of Engerix B (lot AHBV087AB incomplete lot number). On 8/22/2005, 5 days after vaccination with Engerix B, the subject tested positive for hepatitis B surface antigen. On 8/26/2005, the subject retested and was negative for hepatitis b surface antigen. The pharmacist considered the positive test for hepatitis B surface antigen to be related to vaccination with Engerix B. The pharmacist also reported that the lab test was done too soon with regard to dose. Hospital policy is to have a three week lapse between dose and lab.
Mother reports that about 3 to 4 hours after vaccine was given child was thought to be having an anxiety attack. Mother took child to  Hospital. She reports that child's blood pressure (BP) and heart rate were both elevated. She says child was given fluids and sent home. Child had another episode the next day and was then taken to Hospital where she was given a steroid which has seemed to help. She did take child to PCP as well. She is checking her BP twice daily and will take readings to PCP for review in about 3 weeks. She says that the systolic BP was 107 when she last checked it but can't remember what the bottom number was.
Chills; fever greater than 101 degrees; tired; fast heart beat; nausea; shortness of breath; This is a spontaneous report from a contactable consumer (patient). This 59-year-old non pregnant female consumer received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EL9266), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:00 as DOSE 2, SINGLE for covid-19 immunisation (Age at vaccination 59 Years). The patient medical history was not reported. Concomitant medication(s) included celecoxib (CELEXA [CELECOXIB]). Historical vaccine includes dose 1 bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EN5318) on 25Jan2021 10:30 AM on Right arm. No other vaccine in four weeks. No Covid prior vaccination. No Covid tested post vaccination. No known allergies. On 20Feb2021 02:30 patient experienced chills, fever greater than 101 degrees, tired, fast heartbeat, nausea, shortness of breath. The patient underwent lab tests and procedures which included body temperature: 101 on 20Feb2021 fever greater than 101 degrees, body temperature: greater on 20Feb2021 fever greater than 101 degrees, heart rate: fast on 20Feb2021 fast heartbeat. The outcome for all events was recovering.   No follow-up attempts are possible. No further information is expected.
Pain in shoulder that required some medical attention. When I went to the doctor, they ordered an MRI and that is what showed I had cancer. Then a biopsy was ordered and the doctors identified the kind of cancer. Surgical procedure followed by chemotherapy was given as an option. Started on chemo on 12/10/2022 and will be finished in a few weeks (4 months). Currently doing physical therapy and it seems to be helping.
5/30/2018: 2 am chills, 8 am nausea, muscle pain, tiredness, dizzy, throwing up, warmth, redness and swelling at injection site, very sore to the touch. After throwing up at 9am I felt a little better, continued to feel better as day went on...there is still redness, pain on touch, warmth and swelling at injection site 3 days later- 6/2/18.
Pt began crying, "screeching" w/in 2 hrs of vax; mom states pt became hoarse from crying; mom states this lasted x 3 days; temp to 101; mom tx w/APAP; mom called MD but pt did not see MD;
BetweenAug90 + Nov90 pt vax w/ 3rd hepta B which was expired material.  No adverse experience.
This spontaneous report as received from a physician, via a company representative, refers to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. Approximately in 2014, reported as "approximately year ago", the patient was vaccinated with her first dose of GARDASIL, one single shot, intramuscular (lot number and expiration date were not provided). No concomitant therapies were reported. The physician reported that the patient experienced Bell's palsy after being the vaccinated. The therapy with GARDASIL was discontinued. The outcome of VIIth nerve paralysis was unknown at the time of this report. The reporter did not provide a causality assessment for the event. Additional information has been requested.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium
It was several days of round the clock diarrhea. When I started having symptoms of dehydration I was told to go to the ER. They ran a series of tests and everything came back negative. I have a history giardia (parasite in the bowel) and they thought it could be that, but it wasn't. After about 6 days it started to clear up with medication.
My right arm was sore, more so then the 1st 2 shots.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) as dose 1, single and administered in arm right (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Immune deficiency" (unspecified if ongoing), notes: Immune deficiency; "Exercise induced asthma" (unspecified if ongoing); "PTSD" (unspecified if ongoing), notes: Post-traumatic stress disorder; "Depression" (unspecified if ongoing); "Panic disorder" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "My right arm was sore, more so then the 1st 2 shots.".  Additional information: Reaction(s)/Event(s): 3rd dose of vaccine was administered in the right arm. Her right arm was sore, more so then the 1st 2 shots. She had a few light heart flutters the 1st 2 days, but nothing serious. She had moments of feeling flush to the skin, but not feverish. 3 day. Date of start of reaction/event: 31Aug2021. Facility where the most recent COVID-19 vaccine was administered: Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications were received by the patient within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date: 03Sep2021. Reported Event:  She had moments of feeling flush to the skin, but not feverish. 3 days ago, it felt like she was starting to break out on her right cheek and just thought of it as a possible acne reaction to stress. Yesterday, the lesion started on my right side and the bumps felt blotchy vice like acne. Yesterday, she had tenderness under my armpit and outer part of her boob and took it as the soreness from her arm was spreading and prolonged wear of her bra. This morning, her arm hurt less, but under her arm and near her outer boob area it was a little tender. Some tenderness on the right side of her throat, like the lymph nodes might have been swollen in those 2 areas. Tonight she looked online to see if bupropion could be causing this. It was possible, but the symptoms didn't start until after the 3rd Pfizer shot. Left side was fine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. Follow-up attempts completed. No further information is expected.